A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1992

Conditions
HIV Infections
Interventions
DRUG

Foscarnet sodium

Trial Locations (11)

10021

Mem Sloan - Kettering Cancer Ctr, New York

10029

Mount Sinai Med Ctr, New York

11373

City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst

29169

Julio Arroyo, West Columbia

55455

Univ of Minnesota, Minneapolis

90033

Los Angeles County - USC Med Ctr, Los Angeles

USC School of Medicine / Norris Cancer Hosp, Los Angeles

98105

Univ of Washington, Seattle

117948153

SUNY - Stony Brook, Stony Brook

432101228

Ohio State Univ Hosp Clinic, Columbus

921036325

Univ of California / San Diego Treatment Ctr, San Diego

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH